Articles by Lim Jeong-yeo
Lim Jeong-yeo
-
SD Biosensor’s coronavirus test kit gains US FDA’s emergency use approval
SD Biosensor said Friday it has become the third Korean COVID-19 test kit maker to gain US Food and Drug Administration’s emergency use approval. The company’s nCoV Real-Time Detection Kit was already being exported to the US under deals with Federal Emergency Management Agency. The official EUA is anticipated to increase the export volume. With the addition of SD Biosensor, currently three Korean companies including Osang Healthcare and Seegene now have the FDA’s EUA. By L
Industry April 24, 2020
-
Boryung Pharma posts upbeat Q1 earnings, but outlook cloudy
Boryung Pharmaceutical on Friday announced over 40 percent on-year increase in its operating profit in the first quarter, but also expressed concerns for the next quarter. The company’s consolidated revenue for the first quarter rose 13 percent to 134.2 billion won ($109 million), while operating profit rose 42 percent to 13.3 billion won and net profit slid 6 percent to 8.3 billion won. It said its anti-hypertension drug Kanarb’s domestic performance led to good business last year
Industry April 24, 2020
-
Samsung’s smart TVs integrate Apple Music app
Samsung Electronics said Friday its smart TVs will have an Apple Music app embedded in all models. The upgrade is immediately effective worldwide -- excluding South Korea. Consumers in over 100 countries will now be able to enjoy Apple Music on Samsung TVs, without having to download the app. Korea, however, was not included due to Apple’s policy. The local unit of the US-based tech giant did not comment. Samsung is officially the first TV brand to integrate Apple Music on its Smart
Industry April 24, 2020
-
Quick COVID-19 vaccine development unrealistic: Institut Pasteur Korea CEO
It is great to have a positive attitude in scientific endeavors, but to trumpet unrealistic projections rings alarm bells. And the latest attempt to develop vaccines for COVID-19 may be the case, according to Ryu Wang-shick, CEO of Institut Pasteur Korea, on Thursday. “Most vaccine developments fail. We are hearing positive news regarding the COVID-19 vaccine development efforts -- but that’s hope, not reality,” Ryu said. IPK had invited French Ambassador to Korea Philippe L
Industry April 23, 2020
-
Samsung Biologics sees boost in contracts with partners getting green light
Samsung Biologics’ partner Immunomedics having its drug approved by the US Food and Drug Adminsitration has led to an increase in contract volume, according to the Korean contract developer on Thursday. Immunomedics, a biotech firm based in New Jersey, had its sacituzumab govitecan drug approved as an antibody-drug conjugate for metastatic triple-negative breast cancer. The company has thus increased the amount of drugs to be contract-manufactured by Samsung Biologics from the previous
Industry April 23, 2020
-
Seegene’s COVID-19 test kits get FDA emergency approval
Seegene said Wednesday it real-time PCR test kits were granted the US Food and Drug Administration’s emergency use authorization for COVID-19 testing. The company’s Allplex 2019-nCoV Assay has already sold over 10 million tests globally in over 60 countries. Allplex can identify three different target genes -- E, RdRP and N genes -- in a single reaction tube, which maximizes throughput for high volume testing. Seegene is now exporting 3 million test kits every week, and plans to e
Industry April 22, 2020
-
Medytox response draws ire from shareholders
Medytox’s claims that its botulinum toxin product Meditoxin presents no safety issues is drawing ire from shareholders and skepticism from the Drug Ministry. The Korean Drug Ministry suspended the manufacturing and sale of Meditoxin on April 17 due to concerns that the product was made using unapproved materials between 2012 and 2015. On Tuesday, Medytox released a statement saying it had filed an administrative complaint with the ministry, asking it to reverse the suspension order on t
Industry April 22, 2020
-
Korean pharmas form unprecedented alliance to fight pandemic
Governmental organizations and the pharma industry are of the same mind in South Korea when it comes to the urgency of the need to fight COVID-19. The Korea Pharmaceutical and Bio-Pharma Manufacturers Association said Wednesday it will push for members to make joint investments for co-developing vaccines and treatments for the global virus pandemic. This will involve establishing a joint venture, and a combined fund from both the industry and government bodies, with further details to be alig
Industry April 22, 2020
-
[팟캐스트] (349) 초고령화 사회 / 코로나19, 심장에도 영향?
진행자: 임정요, Kevin Lee Selzer 1. Korea set to be superaged society within 4 years 아이튠즈(아이폰): https://itunes.apple.com/kr/podcast/koliaheleoldeu-paskaeseuteu/id686406253?mt=2 팟빵 (안드로이드): http://www.podbbang.com/ch/6638 요약: 한국, 2024년이면 세계에서 여덟번째로 초고령화 사회 진입. [1] South Korea is projected to become one of eight superaged societies in the world by 2024, alongside the existing five -- Japan, Italy, Germany, Sweden and France -- and two other candidates like to ascend -- Canada and the UK. *su
Podcast April 22, 2020
-
Ministry approves Samsung’s blood-pressure app
Samsung Electronics’ blood pressure measuring mobile application Samsung Health Monitor was approved by South Korean authorities Tuesday. The Ministry of Food and Drug Safety said that this is the first time worldwide that a software has been approved to be able to sense a person’s blood pressure without the use of a second device, such as a cuff. Cuffs are arm bands that electronically contract to measure a person’s upper and lower blood pressure. The devices cost from $55
Industry April 21, 2020
-
Samsung Biologics turns profit in Q1
Samsung Biologics posted a 65.27 percent on-year increase in revenue and posted an operating profit in the first quarter of 2020, the company notified shareholders Monday. Samsung Biologics tentatively estimates 207.2 billion won ($169 million) in revenue and 62.6 billion won in operating profit. Net profit marked 39.1 billion won. Samsung Biologics explained that the shifted composition of the biologics drug products being manufactured in its first plant, and the increased sales of th
Industry April 20, 2020
-
Medytox requests suspension to halt of Meditoxin sales
Medytox, Korea’s largest botulinum toxin maker by market share, said Monday that it has submitted a request for suspension of execution on the Drug Ministry’s order to halt manufacturing and sales of its cash cow Meditoxin. While apologizing to customers and investors for causing concern, Medytox argued that the ministry’s order was based on dated findings, and there were no reports of Meditoxin products causing severe adverse effects in the 20 years it has been on the marke
Industry April 20, 2020
-
Electronic firms stick to 2020 plans
The South Korean electronics sector is continuing to push through its original plans of business investment and expansion for 2020 despite the uncertainty cast by the COVID-19 pandemic. According to industry sources Sunday, the Korean electronics companies spanning batteries, displays and semiconductors are showing no signs of drawing back from their overseas plant construction timelines. On the semiconductors frontier, Samsung Electronics is aided by the Foreign Affairs Ministry as it talks
Industry April 19, 2020
-
Half of global pharmas in Korea downsize
Multinational pharmaceutical firms in South Korea are reducing their local workforce -- 48 percent companies slashed staff last year -- according to the Financial Supervisory Service on Thursday. Data showed that 14 companies out of 29 foreign pharmas reduced the number of employees as they suffered lackluster business performances. Combined, however, the overall employment increased from the previous year’s 6,714 to 6,884, up 170. Sanofi-Aventis Korea was the biggest contributor to the
Industry April 17, 2020
-
[Herald Interview] What AI can do for medicine
AI assistance can dramatically change the medical landscape for the better, said Jung Kyu-hwan, chief technology officer and co-founder of medical AI company Vuno, in an interview with The Korea Herald. What AI can do is becoming clearer, giving show recommendations on Netflix and book recommendations on Amazon. It may seem inscrutable how AI works, but really, when simplified, what it does is perform multiplications and additions in colossal volumes, simultaneously. In short, it is a task tha
Industry April 16, 2020
Most Popular
-
1
Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
-
2
Wealthy parents ditch Korean passports to get kids into international school
-
3
Man convicted after binge eating to avoid military service
-
4
First snow to fall in Seoul on Wednesday
-
5
Final push to forge UN treaty on plastic pollution set to begin in Busan
-
6
Korea to hold own memorial for forced labor victims, boycotting Japan’s
-
7
Nvidia CEO signals Samsung’s imminent shipment of AI chips
-
8
Job creation lowest on record among under-30s
-
9
NK troops disguised as 'indigenous' people in Far East for combat against Ukraine: report
-
10
Opposition leader awaits perjury trial ruling